N. Novielli

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

M. Ellis, Y. Tao, L. Harris, 2007, Breast Cancer Research and Treatment.